• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

uniQure

The Capitol Building in Washington DC with bright blue sky - stock photo Becky WrightGetty Images
Biotech

‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections

“The stories are so outrageous,” Sen. Johnson told Bloomberg about recent FDA rebuffs. “It just appears that they’re looking for excuses to say no.”
Gabrielle Masson Mar 10, 2026 11:10am
FDA stop sign

Senior FDA official fires back at uniQure amid controversy

Mar 5, 2026 3:33pm
tennis racket hitting ball

UniQure, FDA back-and-forth intensifies

Mar 5, 2026 11:55am
stop train halt end road block railway

FDA demands ph. 3 trial of uniQure's Huntington's gene therapy

Mar 2, 2026 10:45am
pause button on blue background

UniQure halts mid- to high-dosing for AAV gene therapy

Feb 6, 2026 10:56am
uturn

uniQure's gene therapy for Huntington's hits FDA roadblock

Nov 3, 2025 10:03am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings